9. Shen L, Kato K, Kim SB, et al. Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302) : A Randomized Phase III Study. J Clin Oncol ...
在一项Ⅱ期多中心临床试验中采用西妥昔单抗和纳武利尤单抗联合治疗以确定复发性和(或)转移性(recurrent and/or metastatic,R/M)头颈部鳞状细胞癌(head and neck squamous cell carcinoma,HNSCC)患者的OS发现,西妥昔单抗和纳武利尤单抗的联合治疗是一种...
For more information, see American Academy of Dermatology Association: https://www.aad.org/public/diseases/skin-cancer/squamous-cell-carcinoma. b Principles of Pathology (SCC-A). c Stratification to Determine Treatment Options and Follow-up for Local CSCC Based on Risk Factors for Local Recurrence...
见疗效评估 (ESOPH-5) PRIMARY TREATMENT FOR MEDICALLY FIT PATIENTS WITH SQUAMOUS CELL CARCINOMA RESPONSE ASSESSMENT OUTCOME ADDITIONAL MANAGEMENT Preoperative chemoradiation * CT scan with contrast (not required if PET/CT is done) * PET/CT or PET (category 2B) * Upper GI endoscopy and biopsy (opt...
SURGICAL OUTCOMES/CLINICAL PATHOLOGIC FINDINGS FOR SQUAMOUS CELL CARCINOMA (Patients Have Not Received Preoperative Chemoradiation) TUMOR CLASSIFICATION POSTOPERATIVE MANAGEMENT R0 resection Node negative or p Any T, Any N Surveillance Follow up (see ESOPH-9) Node positive R1 resection Chemoradiation (Fluoro...
UpdatesinVersion1.2025oftheNCCNGuidelinesforSquamousCellSkinCancerfromVersion1.2024include: SCC-F1of4 •FieldCancerization/ConfluentEpidermalDysplasia(SCC-2),sixthbulletrevised:Focalsquamouscellcarcinomainsituarisingwithinactinickeratosis isnotappropriateforsurgeryandshouldbetreatedtopically. ...
Switch maintenance therapy with pemetrexed is recommended (category 2B) in patients with non-squamous cell carcinoma who are negative for ALK rearrangements or sensitizing EGFR mutations. 在ALK重排或敏感EGFR突变阴性的非鳞状细胞癌患者中,推荐用培美曲塞转换维持治疗(2B类)。
(SCC-C) ●治疗原则 (SCC-D) ●放疗原则 (SCC-E) ●系统性治疗原则 (SCC-F) ●PDEMA技术原则 (SCC-G) ●分期 (ST) 检查、诊断和风险状况 (SCC-1) 英文版 中文版 脚注: a.有关更多信息,请参阅美国皮肤科协会: /public/diseases/skin-cancer/squamous-cell-carcino ma. b.见病理学检查原则 (SCC...
2021.V2+NCCN临床实践指南:外阴癌.pdf,® NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Vulvar Cancer (Squamous Cell Carcinoma) Version 2.2021 — October 19, 2020 NCCN.org Continue ® ® ® Version 2.2021, 10/19/20 © 2020 Nati
PET, PET/CT, and Head and Neck Squamous Cell Carcinoma: Is it time to Review the NCCN Guidelines?nasal injuryathleteclosed reduction of nasal fractureObjective: To determine if patients with spontaneous cerebrospinal fluid (CSF) rhinorrhea developed symptoms consistent with idiopathic intracranial ...